251 related articles for article (PubMed ID: 11435752)
21. [Serum soluble adhesion molecules--sICAM-1, sVCAM-1, sE-selectin--in patients with systemic rheumatoid arthritis].
Kuryliszyn-Moskal A; Klimiuk PA; Sierakowski S
Pol Merkur Lekarski; 2004 Oct; 17(100):353-6. PubMed ID: 15690700
[TBL] [Abstract][Full Text] [Related]
22. Different patterns of soluble adhesion molecules in systemic and cutaneous lupus erythematosus.
Nyberg F; Acevedo F; Stephansson E
Exp Dermatol; 1997 Oct; 6(5):230-5. PubMed ID: 9450625
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of the clinical utility of cerebrospinal fluid (CSF) indices of inflammatory markers in multiple sclerosis.
McMillan SA; McDonnell GV; Douglas JP; Hawkins SA
Acta Neurol Scand; 2000 Apr; 101(4):239-43. PubMed ID: 10770519
[TBL] [Abstract][Full Text] [Related]
24. Soluble intercellular adhesion molecule-I (sICAM-I) in serum and cerebrospinal fluid of demyelinating diseases of the central and peripheral nervous system.
Trojano M; Avolio C; Ruggieri M; De Robertis F; Giuliani F; Paolicelli D; Livrea P
Mult Scler; 1998 Feb; 4(1):39-44. PubMed ID: 9532592
[TBL] [Abstract][Full Text] [Related]
25. Pentraxin 3 as a biomarker of local inflammatory response to vascular injury in systemic lupus erythematosus.
Cieślik P; Hrycek A
Autoimmunity; 2015 Jun; 48(4):242-50. PubMed ID: 25401491
[TBL] [Abstract][Full Text] [Related]
26. Markedly elevated soluble intercellular adhesion molecule 1, soluble vascular cell adhesion molecule 1 levels, and blood-brain barrier breakdown in neuromyelitis optica.
Uzawa A; Mori M; Masuda S; Kuwabara S
Arch Neurol; 2011 Jul; 68(7):913-7. PubMed ID: 21747031
[TBL] [Abstract][Full Text] [Related]
27. Elevated soluble intercellular adhesion molecule-1 levels in patients with systemic lupus erythematosus: relation to insulin resistance.
Tso TK; Huang WN
J Rheumatol; 2007 Apr; 34(4):726-30. PubMed ID: 17309130
[TBL] [Abstract][Full Text] [Related]
28. Effects of intravenous methylprednisolone therapy on leukocyte and soluble adhesion molecule expression in MS.
Droogan AG; Crockard AD; McMillan SA; Hawkins SA
Neurology; 1998 Jan; 50(1):224-9. PubMed ID: 9443484
[TBL] [Abstract][Full Text] [Related]
29. Impact of cladribine on soluble adhesion molecules in multiple sclerosis.
Mitosek-Szewczyk K; Stelmasiak Z; Bartosik-Psujek H; Belniak E
Acta Neurol Scand; 2010 Dec; 122(6):409-13. PubMed ID: 20175758
[TBL] [Abstract][Full Text] [Related]
30. Dynamics of soluble adhesion molecule levels in patients with pollinosis.
Kato M; Hattori T; Matsumoto Y; Nakashima I
Arch Otolaryngol Head Neck Surg; 1996 Dec; 122(12):1398-400. PubMed ID: 8956759
[TBL] [Abstract][Full Text] [Related]
31. Subclinical disease activity in systemic lupus erythematosus: immunoinflammatory markers do not normalize in clinical remission.
Wais T; Fierz W; Stoll T; Villiger PM
J Rheumatol; 2003 Oct; 30(10):2133-9. PubMed ID: 14528506
[TBL] [Abstract][Full Text] [Related]
32. [Assessment of serum levels of adhesion molecules (sICAM-1, sVCAM-1, sE-selectin) in stable and unstable angina and acute myocardial infarction].
Bossowska A; Kiersnowska-Rogowska B; Bossowski A; Galar B; Sowiński P
Przegl Lek; 2003; 60(7):445-50. PubMed ID: 14750416
[TBL] [Abstract][Full Text] [Related]
33. Different blood-brain-barrier disruption profiles in multiple sclerosis, neuromyelitis optica spectrum disorders, and neuropsychiatric systemic lupus erythematosus.
Jasiak-Zatońska M; Pietrzak A; Wyciszkiewicz A; Więsik-Szewczyk E; Pawlak-Buś K; Leszczyński P; Kozubski W; Michalak S; Kalinowska-Łyszczarz A
Neurol Neurochir Pol; 2022; 56(3):246-255. PubMed ID: 35118639
[TBL] [Abstract][Full Text] [Related]
34. Soluble adhesion molecules and interleukin-2 receptor concentrations in patients with autoimmune chronic hepatitis.
Simpson KJ; Jones AL; Forbes Howie A; Hayes PC
Eur J Gastroenterol Hepatol; 1995 May; 7(5):455-60. PubMed ID: 7542148
[TBL] [Abstract][Full Text] [Related]
35. Circulating soluble adhesion molecules in patients with giant cell arteritis. Correlation between soluble intercellular adhesion molecule-1 (sICAM-1) concentrations and disease activity.
Coll-Vinent B; Vilardell C; Font C; Oristrell J; Hernández-Rodríguez J; Yagüe J; Urbano-Márquez A; Grau JM; Cid MC
Ann Rheum Dis; 1999 Mar; 58(3):189-92. PubMed ID: 10364919
[TBL] [Abstract][Full Text] [Related]
36. Tumor necrosis factor induced adhesion molecule serum concentrations in Henoch-Schönlein purpura and pediatric systemic lupus erythematosus.
Gattorno M; Vignola S; Barbano G; Sormani MP; Sabatini F; Buoncompagni A; Picco P; Pistoia V
J Rheumatol; 2000 Sep; 27(9):2251-5. PubMed ID: 10990243
[TBL] [Abstract][Full Text] [Related]
37. Soluble adhesion molecules in acute ischemic stroke.
Simundic AM; Basic V; Topic E; Demarin V; Vrkic N; Kunovic B; Stefanovic M; Begonja A
Clin Invest Med; 2004 Apr; 27(2):86-92. PubMed ID: 15202827
[TBL] [Abstract][Full Text] [Related]
38. Influence of age and dietary fish oil on plasma soluble adhesion molecule concentrations.
Miles EA; Thies F; Wallace FA; Powell JR; Hurst TL; Newsholme EA; Calder PC
Clin Sci (Lond); 2001 Jan; 100(1):91-100. PubMed ID: 11115423
[TBL] [Abstract][Full Text] [Related]
39. Soluble intercellular adhesion molecule-1 in serum and cerebrospinal fluid of clinically active relapsing-remitting multiple sclerosis: correlation with Gd-DTPA magnetic resonance imaging-enhancement and cerebrospinal fluid findings.
Trojano M; Avolio C; Simone IL; Defazio G; Manzari C; De Robertis F; Calò A; Livrea P
Neurology; 1996 Dec; 47(6):1535-41. PubMed ID: 8960741
[TBL] [Abstract][Full Text] [Related]
40. Soluble adhesion molecules (sVCAM-1 and sICAM-1) in cerebrospinal fluid and serum correlate with MRI activity in multiple sclerosis.
Rieckmann P; Altenhofen B; Riegel A; Baudewig J; Felgenhauer K
Ann Neurol; 1997 Mar; 41(3):326-33. PubMed ID: 9066353
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
